WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / June 2026 / K261866

510(k) cleared

Concerto Versa Detachable Coil

Medtronic, Inc. · Jun 24, 2026 · K261866

FDA cleared the Concerto Versa Detachable Coil from Medtronic, Inc. on Jun 24, 2026 under K261866, a special 510(k). The device falls under product code KRD, Device, Vascular, For Promoting Embolization, regulated at 21 CFR 870.3300 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Jun 4, 2026. The decision came 20 days later, inside the 90 FDA-day goal for a 510(k).

Medtronic, Inc. has 8 other decisions in the tracker over the last 12 months: K261335 (VitalFlow Set with Balance Biosurface), K253530 (Trexon Monofilament Synthetic Absorbable Suture), K260195 (Elongated One-Piece Arterial (EOPA) 3D Arterial Cannulae), K253203 (Retrograde Coronary Sinus Perfusion Cannulae).

Questions & Answers

What did FDA clear under K261866?

K261866 is the FDA 510(k) for Concerto Versa Detachable Coil, submitted by Medtronic, Inc.. FDA's decision date was Jun 24, 2026, under product code KRD (Device, Vascular, For Promoting Embolization).

Who makes the Concerto Versa Detachable Coil?

Medtronic, Inc., based in Plymouth, MN, is the applicant of record for K261866.

How long did the K261866 review take?

FDA received the submission on Jun 4, 2026 and issued its decision on Jun 24, 2026, 20 days later.

← All decisions in June 2026